Competence Tandem, Innovation Incubator, Leuphana University Lüneburg , Lüneburg , Germany ; Department of Psychiatry, Psychotherapy and Psychosomatics, Center for Social Psychiatry, University Hospital of Psychiatry , Zurich , Switzerland.
Department of Psychiatry, Psychotherapy and Psychosomatics, Center for Social Psychiatry, University Hospital of Psychiatry , Zurich , Switzerland.
Front Public Health. 2014 May 8;2:40. doi: 10.3389/fpubh.2014.00040. eCollection 2014.
Although antidepressants play a major role in the treatment of patients with depression, it is unclear which specific antidepressants are more efficacious than others. This study aims to analyze the relationship between several antidepressant substances and the time to readmission as well as the probability of being in hospital in a given week by using prescription data.
The database was health-insurance claim data from the new Federal States in Germany. The analysis consisted of all patients with unipolar depression at their index admission in 2007 (N = 1803). Patients were followed up for 2 years after discharge from index hospitalization. Statistical analyses were conducted by discrete-time hazards models and general estimation equation models, accounting for various predictors.
Of all prescribed antidepressant substances, sertraline was related to an increased time to readmission by 37% and to a reduction in the probability of being in hospital in a given week by 40%. However, it was prescribed to only about 5% of the patients.
In this study, only sertraline appeared to have clinical and economic advantages. It is remarkable that just a minority of patients received sertraline in our study, thus differing from the prescription pattern in the US.
尽管抗抑郁药在治疗抑郁症患者方面发挥着重要作用,但尚不清楚哪些特定的抗抑郁药比其他药物更有效。本研究旨在通过使用处方数据来分析几种抗抑郁药物与再入院时间以及某一周住院概率之间的关系。
该数据库是来自德国新联邦州的医疗保险索赔数据。分析包括 2007 年索引入院时患有单相抑郁症的所有患者(N=1803)。患者在索引住院出院后随访 2 年。通过离散时间风险模型和广义估计方程模型进行统计分析,考虑了各种预测因素。
在所有开处的抗抑郁药物中,舍曲林与再入院时间延长 37%和某一周住院概率降低 40%相关。然而,它仅被处方给约 5%的患者。
在这项研究中,只有舍曲林似乎具有临床和经济优势。值得注意的是,在我们的研究中只有少数患者接受了舍曲林治疗,这与美国的处方模式不同。